$33.91
1.604.95%
At close: -
$33.91
0.000.00%
After Hours: 4:06 PM EDT
Comments
Loading...
BridgeBio Pharma Earnings Estimates, EPS & Revenue | NASDAQ:BBIO | Benzinga
BridgeBio Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$-0.860
Quarterly Revenue Estimate
$57.14M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$221.90M
Analyze the earnings history of BridgeBio Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma | -$0.20 | -$0.86 | — | — | $211.12M | $57.14M | — | — | 05/01/2025 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.96 | -$1.09 | -$1.40 | -28.44% | $1.75M | $4.04M | $5.88M | 45.59% | 02/20/2025 | Get Alert |
| BBIO | BridgeBio Pharma | -$1.08 | -$0.98 | -$0.86 | 12.24% | $4.09M | $3.76M | $2.73M | -27.34% | 11/12/2024 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.98 | -$1.04 | -$1.06 | -1.92% | $1.64M | $3.57M | $2.17M | -39.27% | 08/01/2024 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.92 | -$0.89 | -$0.20 | 77.53% | $1.83M | $14.03M | $211.12M | 1404.78% | 05/02/2024 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.92 | -$0.91 | -$0.96 | -5.49% | $1.87M | $6.23M | $1.75M | -71.99% | 02/22/2024 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.93 | -$0.81 | -$1.08 | -33.33% | $338.00K | $4.26M | $4.09M | -3.97% | 11/02/2023 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.83 | -$0.83 | -$0.98 | -18.07% | $73.75M | $2.99M | $1.64M | -45.12% | 08/03/2023 | Get Alert |
| BBIO | BridgeBio Pharma | -$1.35 | -$0.83 | -$0.92 | -10.84% | $1.69M | $3.37M | $1.83M | -45.82% | 05/04/2023 | Get Alert |
| BBIO | BridgeBio Pharma | -$1.01 | -$0.85 | -$0.92 | -8.24% | $12.89M | $4.52M | $1.87M | -58.63% | 02/23/2023 | Get Alert |
| BBIO | BridgeBio Pharma | -$1.06 | -$0.99 | -$0.93 | 6.06% | $2.34M | $7.90M | $338.00K | -95.72% | 11/03/2022 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.66 | -$0.63 | -$0.81 | -28.57% | $54.02M | $16.07M | $73.75M | 358.90% | 08/04/2022 | Get Alert |
| BBIO | BridgeBio Pharma | -$1.18 | -$1.11 | -$1.19 | -7.21% | $462.00K | $4.69M | $1.69M | -63.88% | 05/05/2022 | Get Alert |
| BBIO | BridgeBio Pharma | -$1.01 | -$0.87 | -$1.01 | -16.09% | $122.00K | $21.58M | $12.89M | -40.29% | 02/24/2022 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.98 | -$0.90 | -$1.06 | -17.78% | $8.13M | $17.36M | $2.34M | -86.50% | 11/04/2021 | Get Alert |
| BBIO | BridgeBio Pharma | -$1.03 | -$0.96 | -$0.66 | 31.25% | $0.00 | $29.12M | $54.02M | 85.52% | 08/05/2021 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.78 | -$0.80 | -$1.18 | -47.50% | $0.00 | $32.10M | $462.00K | -98.56% | 05/06/2021 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.62 | — | -$1.01 | — | $13.82M | — | $122.00K | — | 02/25/2021 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.51 | — | -$0.98 | — | $26.74M | — | $8.13M | — | 11/05/2020 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.71 | — | -$1.03 | — | $0.00 | — | $0.00 | — | 08/11/2020 | Get Alert |
| BBIO | BridgeBio Pharma | -$0.66 | — | -$0.78 | — | — | — | $0.00 | — | 05/13/2020 | Get Alert |
BridgeBio Pharma (BBIO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-20 | $-1.40 | $-1.09 | -28.4 % |
| Q3 | 2024-11-12 | $-0.86 | $-0.98 | 12.2 % |
| Q2 | 2024-08-01 | $-1.06 | $-1.04 | -1.92 % |
| Q1 | 2024-05-02 | $-0.20 | $-0.89 | 77.5 % |
BridgeBio Pharma (BBIO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-20 | $5.88M | $4.04M | 45.6 % |
| Q3 | 2024-11-12 | $2.73M | $3.76M | -27.3 % |
| Q2 | 2024-08-01 | $2.17M | $3.57M | -39.3 % |
| Q1 | 2024-05-02 | $211.12M | $14.03M | 1404.8 % |
FAQ
When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?
BridgeBio Pharma (BBIO) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 20, 2025 for Q4.
What were the latest earnings per share (EPS) for BridgeBio Pharma (NASDAQ:BBIO)?
The Actual EPS was $-1.40, which missed the estimate of $-1.09.
What were BridgeBio Pharma’s (NASDAQ:BBIO) revenues?
The Actual Revenue was $5.9M, which beat the estimate of $4M.
Browse earnings estimates, EPS, and revenue on all stocks.